Revisiting RECORD4
The Lancet(2022)
Abstract
Findings from the randomised controlled trial of rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty (RECORD4) was published in The Lancet on May 5, 2009, and submitted to the journal long before.1 In October, 2022, concerns about the accuracy of data presented in the Article1 were brought to my attention by a journalist and a Lancet Senior Executive Editor.
MoreTranslated text
Key words
record4
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined